Augustine Therapeutics

Augustine Therapeutics

Discovering and developing innovative medicines for the treatment of neuromuscular and neurodegeneratives diseases. Learn more

Launch date
Employees
Market cap
-
Enterprise valuation
€68—102m (Dealroom.co estimates Jun 2024.)
Company register number 0722.705.230
Leuven Flemish Brabant (HQ)
Authorizing premium user...